Openfund

CORDIS · OHAMR

European Partnership One Health AntiMicrobial Resistance

Code
OHAMR
Programme
HORIZON
Call
European Partnership: One Health Anti-Microbial Resistance HORIZON-HLTH-2024-DISEASE-09-01
Status
SIGNED
Period
2025-06-01 – 2035-05-31
Total cost (whole consortium)253 427 794 €
EU contribution (whole consortium)75 065 264 €
EU contribution to Bulgarian participants78 390 €

Official data · CORDIS · synced 2026-10-17 10:16 · official record

Participants

OrganisationsRoleCountryGrant
VETENSKAPSRADET - SWEDISH RESEARCH COUNCILcoordinatorSE12 684 112 €
UNITED KINGDOM RESEARCH AND INNOVATIONparticipantUK9 919 082 €
AGENCE NATIONALE DE LA RECHERCHEparticipantFR8 544 750 €
BUNDESMINISTERIUM FUER FORSCHUNG TECHNOLOGIE UND RAUMFAHRTparticipantDE6 300 000 €
NEDERLANDSE ORGANISATIE VOOR WETENSCHAPPELIJK ONDERZOEKparticipantNL3 076 616 €
FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICAparticipantIT3 068 445 €
NORGES FORSKNINGSRADparticipantNO2 266 875 €
ZORGONDERZOEK NEDERLAND ZONparticipantNL2 196 094 €
INNOVATIONSFONDENparticipantDK2 192 891 €
AGENCIA ESTATAL DE INVESTIGACIONparticipantES2 174 835 €
MINISTERO DELLA SALUTEparticipantIT2 147 352 €
SERVICE PUBLIC DE WALLONIEparticipantBE1 805 625 €
INSTITUTO DE SALUD CARLOS IIIparticipantES1 648 125 €
FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDERENparticipantBE1 060 664 €
THE HEALTH RESEARCH BOARDparticipantIE1 027 875 €
TAIGHDE EIREANN RESEARCH IRELANDparticipantIE1 024 839 €
MINISTRY OF HEALTHparticipantIL990 375 €
FONDS ZUR FÖRDERUNG DER WISSENSCHAFTLICHEN FORSCHUNGparticipantAT960 465 €
MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKYparticipantCZ935 379 €
FUNDACAO PARA A CIENCIA E A TECNOLOGIAparticipantPT899 062 €
DEPARTMENT OF AGRICULTURE, FOOD AND THE MARINEparticipantIE862 500 €
SUOMEN AKATEMIAparticipantFI835 680 €
XJENZA MALTAparticipantMT738 202 €
SOUTH AFRICAN MEDICAL RESEARCH COUNCILparticipantZA694 214 €
NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATALparticipantHU671 625 €
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMUparticipantTR671 108 €
FONDS DE LA RECHERCHE SCIENTIFIQUE- FNRSparticipantBE646 875 €
HET KONINKLIJK INSTITUUT VOOR DE TROPENparticipantNL605 512 €
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUDparticipantES583 753 €
DEUTSCHES ZENTRUM FUR LUFT - UND RAUMFAHRT EVparticipantDE582 227 €
Lietuvos mokslo tarybaparticipantLT580 008 €
CENTRUM VEDECKO TECHNICKYCH INFORMACII SLOVENSKEJ REPUBLIKYparticipantSK410 625 €
AGES - OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBHparticipantAT345 426 €
AGENTIA NATIONALA PENTRU CERCETARE SI DEZVOLTAREparticipantMD309 886 €
NARODOWE CENTRUM NAUKIparticipantPL295 286 €
EUROPEAN PUBLIC HEALTH ALLIANCEparticipantBE226 871 €
LATVIJAS ZINATNES PADOMEparticipantLV225 000 €
ICARSparticipantDK150 964 €
REGIONAAL- JA POLLUMAJANDUSMINISTEERIUMparticipantEE113 625 €
SIHTASUTUS EESTI TEADUSAGENTUURparticipantEE113 625 €
FORUM DES PATIENTS EUROPEENSparticipantBE104 816 €
FONDAZIONE TOSCANA LIFE SCIENCESparticipantIT99 900 €
THE TRUSTEES OF BOSTON UNIVERSITYparticipantUS97 373 €
BIOTEHNOLOGICHEN I ZDRAVEN KLASTERparticipantBG78 390 €
DEUTSCHES ZENTRUM FUR INFEKTIONSFORSCHUNG (DZIF) EVparticipantDE55 133 €
AICIB - AGENCIA DE INVESTIGACAO CLINICA E INOVACAO BIOMEDICAparticipantPT32 438 €
Department of HealthparticipantUK10 743 €
BUNDESMINISTERIUM FUR FRAUEN, WISSENSCHAFT UND FORSCHUNGparticipantAT0 €
AGENTURA PRO ZDRAVOTNICKY VYZKUM CESKE REPUBLIKY AZV CRthird partyCZ0 €
AGENZIA PER LA PROMOZIONE DELLA RICERCA EUROPEAthird partyIT0 €
DEPARTMENT OF SCIENCE, TECHNOLOGY AND INNOVATIONthird partyZA0 €
ISTITUTO SUPERIORE DI SANITAthird partyIT0 €
GARDP Foundationassociated partnerCH
CANADIAN INSTITUTES OF HEALTH RESEARCHassociated partnerCA
SCHWEIZERISCHER NATIONALFONDS ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNGassociated partnerCH

Description

Antimicrobial resistance (AMR) is a global health challenge with an estimated 67% increase in global deaths attributable to AMR by 2050. The European Partnership One Health AMR (EUP OHAMR) is aiming to reduce the burden of AMR with an integrated One Health (OH) approach, recognising that human, animal and plant health are interdependent and interlinked with the environment. The partnership will boost AMR research and innovation (R&I) addressing the current knowledge gaps with the aim to improve surveillance of resistant pathogens and provide better diagnostics and more effective treatments of drug-resistant infections. It will support implementation research on prevention measures reducing the use of antimicrobials and spread of AMR and launch an ambitious work programme of joint activities to coordinate R&I investments, facilitate the use and re-use of R&I data, strengthen AMR R&I capacities and facilitate both knowledge translation and uptake of research results and innovations by industry, society, and policy makers.The EUP OHAMR builds on the long-standing collaboration of the partners from the Joint Programme Initiative on AMR (JPIAMR) but with a bigger ambition and a broader scope. The partnership consists of 53 partners from 30 countries from the European Union (EU) and beyond. With active engagement of key stakeholders across the AMR landscape, the partnership will strengthen European and global synergies through alignment of research priorities, policies, and investments. Furthermore, EUP OHAMR will support multisectoral and multidisciplinary collaborations to break the existing silos in AMR research. It will result in increased knowledge and solutions and provide an evidence base for uptake into policy and practice to prevent and tackle AMR. Thus, the EUP OHAMR will deliver towards to the priorities set in the European One Health Action plan against AMR, thereby strengthening the European Research and Innovation Area ecosystem and contribute to making the EU a best-practice region on AMR.

Official data · CORDIS · synced 2026-10-17 10:16 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).